Loading...
XJSE
APN
Market cap3.87bUSD
Jun 19, Last price  
15,425.00ZAR
1D
4.17%
1Q
17.38%
Jan 2017
-45.61%
Name

Aspen Pharmacare Holdings Ltd

Chart & Performance

D1W1MN
XJSE:APN chart
P/E
15.55
P/S
1.53
EPS
9.92
Div Yield, %
1.43%
Shrs. gr., 5y
-0.54%
Rev. gr., 5y
2.84%
Revenues
43.36b
-3.00%
3,449,340,0004,025,854,0004,881,273,0008,450,300,00010,146,600,00012,383,200,00015,255,800,00019,308,000,00029,515,100,00036,126,600,00035,600,000,00041,200,000,00042,596,000,00038,872,000,00038,647,000,00037,766,000,00038,606,000,00040,709,000,00044,706,000,00043,363,000,000
Net income
-1.08b
L
638,093,000717,666,000864,476,0001,353,600,0001,978,500,0002,588,800,0002,817,800,0003,520,100,0005,007,600,0005,201,400,0004,300,000,0005,100,000,0006,010,000,0006,463,000,0004,664,000,0004,806,000,0006,488,000,0005,228,000,0004,404,000,000-1,083,000,000
CFO
5.16b
-17.12%
402,213,000708,560,000652,384,0001,292,100,0002,033,000,0002,445,900,0002,908,400,0003,986,100,0003,836,300,0004,838,800,0003,200,000,0006,500,000,0007,017,000,0006,002,000,0008,260,000,0006,825,000,0005,374,000,0005,520,000,0006,225,000,0005,159,000,000
Dividend
Oct 01, 2025210.99999 ZAR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Aspen Pharmacare Holdings Limited is a global pharmaceutical entity that develops, manufactures, and distributes a wide array of specialized and branded medicinal products. The company operates through two primary segments: Commercial Pharmaceuticals and Manufacturing. Its diverse product portfolio encompasses essential anesthetic agents, such as general anesthetics, muscle relaxants, and topical preparations. Aspen also provides a comprehensive suite of thrombosis treatments, including various injectable anticoagulants like low molecular weight heparins, Xa inhibitors, and other heparin derivatives. Beyond these, the firm markets numerous regional consumer, prescription, and over-the-counter brands, such as Circadin for sleep, Foxair for respiratory ailments, Maltofer as an iron supplement, Mybulen for pain management, and Zyloric for gout. Additionally, Aspen produces active pharmaceutical ingredients and finished dose form products for other companies. Established in 1850, the company's headquarters are located in Durban, South Africa.
IPO date
Dec 05, 1994
Employees
8,580
Domiciled in
ZA
Incorporated in
ZA

Valuation

Title
ZAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT